Universidade de Passo Fundo   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Passo Fundo Brazil (1968)

Organization Overview

First Clinical Trial
2010
NCT01065649
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Universidade de Passo Fundo | University of Passo Fundo

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Avitaminosis (Phase 1)

Gastroesophageal Reflux (Phase 3)

Halitosis (Phase 2)

Heartburn (Phase 3)

Intestinal Diseases (Phase 2)

Mucositis (Phase 2)

Pneumonia (Phase 2)

Pneumonia, Ventilator-Associated (Phase 2)

Stomatitis (Phase 2)

Tongue Diseases (Phase 2)

Vitamin D Deficiency (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 12